Rojas-Lechuga, María Jesús
Izquierdo-Domínguez, Adriana
Chiesa-Estomba, Carlos
Calvo-Henríquez, Christian
Villarreal, Ithzel Maria
Cuesta-Chasco, Genoveva
Bernal-Sprekelsen, Manuel
Mullol, Joaquim
Alobid, Isam http://orcid.org/0000-0001-7204-5599
Article History
Received: 3 June 2020
Accepted: 31 July 2020
First Online: 25 August 2020
Compliance with ethical standards
:
: Isam Alobid: Consultant for Roche, Novartis, Mylan, Menarini, MSD. Joaquim Mullol: member of national or international advisory boards, received speaker fees, or funding for clinical trials and research projects from ALK, AstraZeneca, Genentech, GlaxoSmithKline, Glenmark, Menarini, Mitsubishi-Tanabe, MSD, Mylan-MEDA Pharma, Novartis, Regeneron Pharmaceuticals, SANOFI-Genzyme, UCB Pharma, and Uriach Group. The other authors declare that they have no conflicts of interest.
: This study was supported by the Commission of Rhinology and Allergy, Spanish ENT Society (SEORL-CCC).
Free to read: This content has been made available to all.